VistaGen Therapeutics(VTGN) - 2022 Q3 - Earnings Call Transcript

VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q3 2022 Earnings Conference Call February 10, 2022 5:00 PM ET Company Participants Mark Flather - Vice President, Investor Relations Shawn Singh - Chief Executive Officer Jerry Dotson - Chief Financial Officer Mark Smith - Chief Medical Officer Conference Call Participants Andrew Tsai - Jefferies Lachlan Hanbury-Brown - William Blair Luke Herrmann - Baird Joanne Lee - Maxim Group Operator Greetings and welcome to VistaGen Therapeutics’ Third Quarter of Fiscal Year 2 ...